<?xml version="1.0" encoding="UTF-8"?>
<ref id="b83-ir-2019-09155">
 <label>83</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Loomba</surname>
    <given-names>R</given-names>
   </name>
   <name>
    <surname>Liang</surname>
    <given-names>TJ</given-names>
   </name>
  </person-group>
  <article-title>Hepatitis B reactivation associated with immune suppressive and biological modifier therapies: current concepts, management strategies, and future directions</article-title>
  <source>Gastroenterology</source>
  <year>2017</year>
  <volume>152</volume>
  <fpage>1297</fpage>
  <lpage>1309</lpage>
  <pub-id pub-id-type="pmid">28219691</pub-id>
 </element-citation>
</ref>
